Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert D McBane
Academic and Community Cancer Research United
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Cleveland Clinic-Weston
Weston, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Illinois Cancercare-Peoria
Peoria, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Cancer Center of Kansas - Wichita
Wichita, Kansas, United States
- Saint Elizabeth Medical Center South
Edgewood, Kentucky, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Mayo Clinic in Rochester
Rochester, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- New Hampshire Oncology Hematology Pa-Hooksett
Hooksett, New Hampshire, United States
- Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Solinsky Center for Cancer Care
Manchester, New Hampshire, United States
- Montefiore Medical Center - Moses Campus
The Bronx, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Firsthealth of the Carolinas-Moore Regional Hospital
Pinehurst, North Carolina, United States
- Altru Cancer Center
Grand Forks, North Dakota, United States
- University of Washington Medical Center - Montlake
Seattle, Washington, United States
- Mayo Clinic Health System-Eau Claire Clinic
Eau Claire, Wisconsin, United States
- Dean Hematology and Oncology Clinic
Madison, Wisconsin, United States
- Marshfield Medical Center-Marshfield
Marshfield, Wisconsin, United States
- Froedtert and the Medical College of Wisconsin Laps
Milwaukee, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Jul 2017
- Primary completion
- 7 Jun 2022
- Completion
- 9 May 2025
- Last update posted
- 18 May 2025
- Registered enrollment
- 370
- Registry id
- NCT03080883
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.